Cargando…
ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure
BACKGROUND: Inhaled nitric oxide (iNO) reduces death or need for extracorporeal membrane oxygenation (ECMO) in infants with persistent pulmonary hypertension of the newborn (PPHN). However, the response to iNO is variable and only 50–60% of infants demonstrate a response to iNO. It is not known why...
Autores principales: | El-Ferzli, George T., Dreher, Mackenzie, Patel, Rakesh P., Ambalavanan, Namasivayam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440342/ https://www.ncbi.nlm.nih.gov/pubmed/22984626 http://dx.doi.org/10.1371/journal.pone.0045164 |
Ejemplares similares
-
Nitric Oxide Administration Using an Oxygen Hood: A Pilot Trial
por: Ambalavanan, Namasivayam, et al.
Publicado: (2009) -
Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure
por: Konduri, G G, et al.
Publicado: (2013) -
INHALED NITRIC OXIDE IN COVID-19-INDUCED HYPOXEMIC RESPIRATORY FAILURE
por: NAGA YARRARAPU, SIVA, et al.
Publicado: (2021) -
Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
por: Guan, Yi, et al.
Publicado: (2023) -
Inhaled PGE(1) in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials
por: Sood, Beena G, et al.
Publicado: (2014)